Advertisement
Screener

60 DEGREES PHARMACEUTICALS, INC. (SXTP) Form D

60 DEGREES PHARMACEUTICALS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2025-02-12: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2025-02-05; Total offering amount $1,075,003.
  • 2025-02-11: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2025-01-28; Total offering amount $1,043,002.
  • 2023-05-24: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; Date of first sale 2022-05-19; Total offering amount Indefinite.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2025-02-12Rule 506(b)OptionToAcquire2025-02-05$1,075,003$1,075,003$04
2025-02-11Rule 506(b)OptionToAcquire2025-01-28$1,043,002$1,043,002$04
2023-05-24Rule 506(b)Equity; Debt2022-05-19Indefinite$1,755,000Indefinite10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Onconetix, Inc. (ONCO)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
Sunshine Biopharma Inc. (SBFM)$0.003B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24